Salspera
- Biotech or pharma, therapeutic R&D
Salspera is a clinical-stage biotechnology company committed to developing novel therapies for solid tumor cancers. The company has a platform of microbial-based immunotherapies that have the potential to address a range of solid tumor cancers. Saltikva, the lead program, was evaluated in a recently completed, successful Phase 2 clinical study in Stage 4, metastatic pancreatic cancer. Salspera is now looking for partnering opportunities to drive this program to approval in various markets. Salspera also has 2 Phase 2- ready programs in osteosarcoma and CRC, along with next generation pre-IND candidates.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}